Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?What's the recommended schedule for lurbinectedin side effect checks?Albendazole side effects in humans?Guselkumab patent expiration?Bivalirudin manufacturer?
See the DrugPatentWatch profile for keytruda
Keytruda’s first FDA launch approval in the U.S. was for unresectable or metastatic melanoma.
The original approval focused on melanoma before later expansions to many other cancers (for example, lung, head and neck, bladder, and others).
Other Questions About Keytruda :